RBOT — Vicarious Surgical Cashflow Statement
0.000.00%
Annual cashflow statement for Vicarious Surgical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -35.2 | 5.16 | -71.1 | -63.2 | -50.2 |
| Depreciation | |||||
| Non-Cash Items | 0.638 | -70.8 | 8.89 | 12.8 | 8.77 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.955 | 3.36 | -1.98 | -1.6 | -5.09 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -33.3 | -61.2 | -62.3 | -50 | -45.1 |
| Capital Expenditures | -1.29 | -5.35 | -1.67 | -0.18 | -0.132 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -44.1 | 7.04 | 32.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -1.29 | -5.35 | -45.8 | 6.86 | 32.1 |
| Financing Cash Flow Items | 190 | -0.3 | -2.82 | — | -0.696 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 192 | 9.14 | 44.7 | 0.008 | 5.76 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 158 | -57.4 | -63.4 | -43.1 | -7.17 |